Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients.
The endothelium participates in haemostasis, inflammation, blood pressure regulation and other physiological systems. Consequently, endothelial dysfunction has been related to hypertension, thrombosis and atherosclerosis. Both von Willebrand factor (vWF) and tissue-type plasminogen activator (t-PA) are synthesized by the endothelium and their plasma levels increased during endothelium activation or injury. So far, they are well-known markers of endothelial cell function. Many circumstances activate or damage the endothelium, such as viruses, bacterium and inflammation. Circulating vWF and t-PA were studied in 92 unselected human immunodeficiency virus-1 (HIV-1)-infected patients [27 patients with and 65 patients without acquired immunodeficiency syndrome (AIDS)] and correlated with plasma levels of pro-inflammatory cytokines (tumour necrosis factor-alpha, interleukin-6), viral load, CD4 T-cell count and infectious status. HIV-1-infected patients had significantly higher plasma levels of vWF (152 versus 90%), tumour necrosis factor-alpha (31.3 versus 9.0 pg/ml) and interleukin-6 (3.5 versus 1.9 pg/ml) but not t-PA (5.9 versus 4.2 ng/ml) than the control group. These two endothelial markers correlated significantly with viral load and interleukin-6 levels in HIV-1-infected patients. The highest levels of vWF and t-PA were found in patients with AIDS. In conclusion, endothelial cell perturbation is present in HIV infection and may be a consequence of different mechanisms such as viral load, cytokines and advanced diseases.
de Larrañaga
Gabriela F
GF
Haemostasis and Thrombosis Laboratory, Hospital of Infectious Diseases F J Muñiz, Buenos Aires, Argentina. gabyl@inovia.com.ar
Petroni
Alejandro
A
Deluchi
Gabriel
G
Alonso
Beatriz S
BS
Benetucci
Jorge A
JA
D000328:Adult; D015415:Biomarkers / Q000097:blood; D018791:CD4 Lymphocyte Count; D016022:Case-Control Studies; D018450:Disease Progression; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D015658:HIV Infections / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D015497:HIV-1; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008875:Middle Aged; D018709:Statistics, Nonparametric; D010959:Tissue Plasminogen Activator / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D019562:Viral Load; D014841:von Willebrand Factor / Q000032:analysis
D015415:Biomarkers; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator